UAB is ranked No. 164 based on exceptional academic research portfolio and its overall global and regional reputation.

The program seeks to support and foster multidisciplinary collaborations, especially between UAB clinicians and basic and physician scientists.

The MyLupus app is a patient-friendly, patient-focused decision-aid tool for people from all backgrounds with moderate to severe lupus.

Lung-resident memory B cells produced during influenza are long-living immune cells that migrate to the lungs from draining lymph nodes and lie in wait as early responders that can quickly react to future infections. They are key sentinels against subsequent viral variants.

The study, funded by the Patient-Centered Outcomes Research Institute, will compare two pathways of post-fracture patient care.

Knowledge of this previously unrecognized mechanism may aid therapy for patients with interleukin-6 signaling mutations and hyper-IgE Syndrome, or HIES.

Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.

These effector memory B cells appear poised for a rapid serum antibody response upon secondary challenge one year later, and evidence shows that the cells in this subset differ from all previously described memory B cell subsets.

One UAB patient uses her transformational story to spread awareness of scleroderma.

U.S. News & World report named UAB Hospital as the best hospital in Alabama.

UAB rheumatologists will begin seeing patients at the UAB Hoover Primary Care clinic in July 2022.

A detailed mechanistic study unravels how the bacterial endotoxin LPS prevents or promotes allergic disease.

Lupus, an autoimmune disease that can attack any part of the body, can be confounding because patients often respond differently to the same treatment, and they vary widely in the severity of their symptoms.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.

A new multidisciplinary program within UAB Medicine will help evaluate patients who have recovered from COVID-19 but are still experiencing symptoms and link them to the specialized care they need.

This study included preclinical experiments and use of bronchoalveolar cells from IPF patients.